Antidepressants in ‘Depressed‘ Schizophrenic Inpatients: A Controlled Trial

Archives of General Psychiatry

Volumn 46, Issue 10, 1989, Pages 922-928

  Kramer, Mark S ^a   Vogel, Wolfgang H ^a   Dijohnson, Celeste ^b   Dewey, Donna Ann ^a   Sheves, Patricia ^b   Cavicchia, Steven ^b   Litle, Patrick ^b   Schmidt, Robert ^b   Kimes, Iva ^b  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b Coatesville ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; BENZATROPINE; DESIPRAMINE; HALOPERIDOL;

ADULT; DEPRESSION; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; SCHIZOPHRENIA; THOUGHT DISORDER;

ADOLESCENT; ADULT; AMITRIPTYLINE; BENZTROPINE; CLINICAL TRIALS; COMPARATIVE STUDY; DEPRESSIVE DISORDER; DESIPRAMINE; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HALOPERIDOL; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGE; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUPPORT, U.S. GOV'T, NON-P.H.S.;

EID: 0024459594     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1989.01810100064012     Document Type: Article

References (49)

1. Becker RE. Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia. Am J Psychiatry. 1983;140:208-211.
2. Becker RE, Colliver JA, Verhulst SJ. Diagnosis of secondary depression in schizophrenia. J Clin Psychiatry. 1985;46:4-8.
3. Becker RE, Singh MM, Meisler N, Shillcutt S. Clinical significance evaluation, and management of secondary depression in schizophrenia. J Clin Psychiatry. 1985;46:26-32.
4. Galdi J. The causality of depression in schizophrenia. Br J Psychiatry. 1983;142:621-625.
5. Hirsch SR. Depression ‘revealed’ in schizophrenia. Br J Psychiatry. 1982;140:421-424.
6. Johnson DAW. Studies of depressive symptoms in schizophrenia. Br J Psychiatry. 1981;139:89-101.
7. Lerner Y, Moscovich D. Depressive symptoms in acute schizophrenic hospitalized patients. J Clin Psychiatry. 1985;46:483-484.
8. Mandel MR, Severe JB, Schooler NR, Gelenberg AJ, Mieske M. Development and prediction of postpsychotic depression in neuroleptic-treated schizophrenics. Arch Gen Psychiatry. 1982;39:197-203.
9. Martin RL, Cloninger R, Guze SB, Clayton PJ. Frequency and differential diagnosis of depressive syndromes in schizophrenia. J Clin Psychiatry. 1985;46:9-13.
10. Möller H-J, von Zerssen D. Depressive states occurring during the neuroleptic treatment of schizophrenia. Schizophr Bull. 1982;8:109-117.
11. Prusoff BA, Williams DH, Weissman MM. Treatment of secondary depression in schizophrenia. Arch Gen Psychiatry. 1979;36:569-575.
12. Roy A, Thompson R, Kennedy S. Depression in chronic schizophrenia. Br J Psychiatry. 1983;142:465-470.
13. Siris SG, van Kammen DP, Docherty JP. Use of antidepressant drugs in schizophrenia. Arch Gen Psychiatry. 1978;35:1368-1377.
14. Siris SG, Rifkin A. Drug treatment of depression in patients with schizophrenia. In: Rifkin A, ed. Schizophrenia and Affective Disorders. Littleton, Mass: John Wright-PSG Inc; 1983:281-297.
15. Siris SG, Rifkin A, Reardon GT, Endicott J, Pereira DH, Hayes R, Casey E. Course-related depressive syndromes in schizophrenia. Am J Psychiatry. 1984;1412:1254-1257.
16. Siris SG, Morgan V, Fagerstrom R, Rifkin A, Cooper TB. Adjunctive imipramine in the treatment of postpsychotic depression: a controlled trial. Arch Gen Psychiatry. 1987;44:533-539.
17. Van Putten T, May PRA. ‘Akinetic’ depression in schizophrenia. Arch Gen Psychiatry. 1978;35:1101-1107.
18. Helmechen H, Hippius H. Depressive Syndrome im Verlauf neuroleptischer Therapie. Nervenarzt. 1967;38:445-458.
19. McGlashan TH, Carpenter WT Jr. Postpsychotic depression in schizophrenia. Arch Gen Psychiatry. 1976;33:231-239.
20. Tsuang MT. Suicides in schizophrenics, manics, depressives, and surgical controls. Arch Gen Psychiatry. 1978;35:153-155.
21. Roy A. Risk factors for suicide in psychiatric patients. Arch Gen Psychiatry. 1982;39:1089-1095.
22. Roy A. Suicide in chronic schizophrenia. Br J Psychiatry. 1982;141:171-177.
23. Wilkinson DG. The suicide rate in schizophrenia. Br J Psychiatry. 1982;140:138-141.
24. Brier A, Astrachan BM. Characterization of schizophrenic patients who commit suicide. Am J Psychiatry. 1984;141:206-209.
25. Singh AN, Saxena B, Nelson HL. A controlled study of trazodone in chronic schizophrenic patients with pronounced depressive symptomatology. Curr Therap Res. 1978;23:485-499.
26. Waehrens J, Gerlach J. Antidepressant drugs in anergic schizophrenia: a double-blind cross-over study with maprotiline and placebo. Acta Psychiatr Scand. 1980;61:438-444.
27. Kurland AA, Nagaraju A. Viloxazine and the depressed schizophrenic: methodological issues. J Clin Pharmacol. 1981;21:37-41.
28. Dufresne RL, Kass DJ, Becker RE. Bupropion and thiothixene versus placebo and thiothixene in the treatment of depression in schizophrenia. Drug Dev Res. 1988;12:259-266.
29. Spitzer RL, Endicott J, Robins E. Research Diagnostic Criteria for a Group of Selected Functional Disorders. 3rd ed. New York, NY: Research Biometrics Division, New York State Psychiatric Institute; 1977.
30. Overall JE, Hollister LE, Pichot P. Major psychiatric disorders: a fourdimensional model. Arch Gen Psychiatry. 1967;16:146-151.
31. Rifkin A, Quitkin F, Klein DF. Akinesia. Arch Gen Psychiatry. 1975;32:672-674.
32. Rifkin A, Quitkin F, Kane J, Struve F, Klein DF. Are prophylactic antiparkinsonian drugs necessary? Arch Gen Psychiatry. 1978;35:483-489.
33. Wistedt B, Palmstierna T. Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics. J Clin Psychiatry. 1983;44:369-371.
34. McGlashan TH, Carpenter WT. An investigation of the postpsychotic depressive syndrome. Am J Psychiatry. 1976;133:14-19.
35. Meador-Woodruff JH, Mayada A, Wisner-Carlton R, Grunhaus L. Behavioral and cognitive toxicity related to elevated plasma tricyclic antidepressant levels. J Clin Psychopharmacol. 1988;8:28-32.
36. Moody JP, Tait AC. Plasma levels of imipramine and desipramine during therapy. Br J Psychiatry. 1967;113:183-193.
37. Gram LF, Overo KF. Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. Am J Psychiatry. 1974;131:863-866.
38. Gram LF, Christiansen I. Pharmacokinetic interactions between antidepressants and neuroleptics in the rat. Acta Pharmacol Toxicol. 1974;35:223-232.
39. Gram LF. The effect of perphenazine on imipramine metabolism in man. Psychopharmacol Commun. 1975;1:165-175.
40. Vandel B, Vandel S. Interaction between amitriptyline and phenothiazine in man: effect on plasma concentration of amitriptyline and its metabolite nortriptyline and correlation with clinical response. Psychopharmacology. 1979;65:187-190.
41. Linnoila M, George L. Interactions between antidepressants and perphenazine in psychiatric inpatients. Am J Psychiatry. 1982;139:1329-1331.
42. Siris SG, Cooper TB, Rifkin A, Brenner R, Lieberman J. Plasma imipramine concentrations in patients receiving concomitant fluphenazine decanoate. Am J Psychiatry. 1982;139:104-106.
43. Coryell W, Turner RD, Sherman A. Desipramine plasma levels and clinical response: evidence for a curvilinear response. J Clin Psychopharmacol. 1987;7:138-142.
44. Perry PJ, Pfohl BM, Kelly MW. The relationship of haloperidol concentrations to therapeutic response. J Clin Psychopharmacology. 1988;8:38-43.
45. Baldessarini RJ, Cohen BM, Teicher MH. Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Arch Gen Psychiatry. 1988;45:79-91.
46. Perry PJ, Pfohl BM, Holstad SG. The relationship between antidepressant response and tricyclic antidepressant plasma concentrations. Clin Pharmacokinet. 1987;13:381-392.
47. Donlon PT, Rada RT, Arora KK. Depression and the reintegration phase of acute schizophrenia. Am J Psychiatry. 1976;133:1265-1268.
48. Knights A, Hirsch SR. ‘Revealed’ depression and drug treatment for schizophrenia. Arch Gen Psychiatry. 1981;38:806-811.
49. McGlashan TH, Carpenter WT Jr. Affective symptoms and the diagnosis of schizophrenia. Schizophr Bull. 1979;5:547-553.